Extended CMC studies for the development of 2R,6R-HNK

Ended Awarded Last action

Contract number
75N95020F00001
Awardee
Awarding agency
Obligated
$924,887

Award facts

Opportunity
Contract value 74% obligated
  • $924,886.94 Current, with exercised options
  • $1,242,366.94 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Minneapolis, MN 55455, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00006 -$768
Funding Only Action P00005 -$204,643
Supplemental Agreement for work within scope P00004 $0
Supplemental Agreement for work within scope P00003 $0
Supplemental Agreement for work within scope P00002 $0
Additional Work (new agreement, FAR part 6 applies) P00001 · Extended CMC studies for the development of 2R,6R-HNK. POP 9/21/2020 - 9/20/2021. Modification P00001 adds new work and extends the POP through 5/31/2022. $39,519
Original award $1,090,779

About this award

The National Institute on Drug Abuse issued a delivery order to the Regents of the University of Minnesota on September 18, 2020, with a ceiling value of $1,242,366.94 under the CRO Support for NCATS Drug Substance Development and Manufacture parent vehicle for extended CMC (chemistry, manufacturing, and controls) studies in support of 2R,6R-HNK drug substance development and manufacture, with ultimate completion by May 31, 2026.

Place of performance is Minneapolis, MN. The order is priced on a cost no-fee basis with no set-aside. Service Contract Inventory reporting shows declining labor engagement: FY2021 invoiced $804 thousand across 0.3 FTEs and 566 contractor hours at a blended rate of $1,422.14 per hour; FY2022 invoiced $21 thousand (83 hours at $249.04/hr); FY2023 invoiced $32 thousand (219 hours at $144.02/hr); FY2024 invoiced $56 thousand (84 hours at $671.80/hr); FY2025 invoiced $15 thousand with no reported FTE activity. The university self-performed all reported work across all fiscal years.

Quick answers

Who was awarded contract 75N95020F00001?

75N95020F00001 was awarded to Regents Of The University Of Minnesota by National Institute on Drug Abuse (National Institutes of Health) on September 18, 2020.

How much is contract 75N95020F00001 worth?

The government has obligated $924,887 on 75N95020F00001. Its potential value, with all options, is $1,242,367.

Is contract 75N95020F00001 an order under another contract?

Yes. 75N95020F00001 is a delivery order under HHSN271201700008I, an indefinite delivery contract, on CRO Support for NCATS Drug Substance Development and Manufacture.

Was contract 75N95020F00001 competed?

The extent of competition for 75N95020F00001 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award